Brilliant Violet 421TM anti-human CD124 (IL-4Ralpha) [G077F6] and 3 more items

BioLegend Inc. has been awarded a contract by the University of Virginia on June 9, 2026, to supply specialized flow cytometry reagents and antibodies. The contract, designated A207_PO-0446680, is valued at $1,033.55 and encompasses four distinct immunological reagent line items to be delivered to Glenda Canderan. The products include Brilliant Violet 421 anti-human CD124 (interleukin-4 receptor alpha) monoclonal antibody, PerCP anti-human CD8 antibody, APC/Fire 810 anti-human CD38 antibody, and Pacific Blue anti-human/mouse/rat CD278 (inducible T-cell co-stimulator) antibody, with unit prices ranging from $210.00 to $309.75 per item.

This contract award represents a procurement of research-grade laboratory reagents by the University of Virginia, located in Virginia. The delivery location is specified as Glenda Canderan's facility, and each line item consists of a single unit purchase. No specific period of performance beyond the award date is documented in the available contract information. The cumulative contract value of $1,033.55 reflects the aggregated cost of all four antibody products included in this purchase order.